Cryopreservation Equipment

Cryopreservation Equipment

Global Cryopreservation Equipment Market to Reach US$17.1 Billion by 2030

The global market for Cryopreservation Equipment estimated at US$8.1 Billion in the year 2023, is expected to reach US$17.1 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. Freezers, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Sample Preparation Systems segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 15.5% CAGR

The Cryopreservation Equipment market in the U.S. is estimated at US$2.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 15.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.5% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global Cryopreservation Equipment Market - Key Trends & Drivers Summarized

Why Is Cryopreservation Equipment Vital for Biotechnology and Healthcare?

Cryopreservation equipment is crucial in preserving biological samples, cells, tissues, and organs at ultra-low temperatures, ensuring their long-term viability for medical research, transplantation, and therapy. Cryopreservation is widely used in the biobanking, stem cell research, fertility treatments, and regenerative medicine fields, where the ability to store biological materials without compromising their integrity is essential. The rise in cell-based therapies, advancements in personalized medicine, and the growing need for organ transplants are driving demand for cryopreservation solutions that offer reliable storage and retrieval capabilities.

How Are Technological Advances Enhancing Cryopreservation Equipment?

Technological innovations in cryopreservation equipment are significantly improving storage efficiency, reliability, and sample safety. Advanced cryogenic freezers and liquid nitrogen tanks now offer precise temperature control and monitoring, ensuring that samples remain within the required ultra-low temperature range to prevent degradation. Automation and IoT integration are also transforming cryopreservation, allowing real-time tracking, remote monitoring, and automated sample retrieval. Additionally, innovations in cryoprotectants—compounds that prevent cell damage during freezing—are improving the success rate of preserving more sensitive biological materials, such as stem cells and embryos. These technological advancements are essential in supporting the growing demand for cryopreserved materials in research and clinical applications.

What Regulatory and Safety Standards Shape the Cryopreservation Market?

Regulatory standards in the cryopreservation market are stringent, particularly in sectors such as healthcare and pharmaceuticals, where the integrity of biological samples is critical. Organizations like the FDA, European Medicines Agency (EMA), and International Society for Biological and Environmental Repositories (ISBER) have established guidelines for the proper handling, storage, and transportation of cryopreserved materials. These standards ensure that biological samples are preserved in conditions that maintain their viability for future use in clinical and research settings. Adherence to Good Manufacturing Practices (GMP) is also essential for cryopreservation equipment manufacturers to ensure the safety and reliability of their products in sensitive applications.

What Factors Are Driving the Growth of the Cryopreservation Equipment Market?

The growth in the cryopreservation equipment market is driven by several factors, including the increasing adoption of biobanking, advancements in regenerative medicine, and the growing demand for cell-based therapies. As research into stem cells, immunotherapy, and personalized medicine expands, the need for reliable cryopreservation solutions is becoming more critical. The rise in fertility preservation, driven by delayed parenthood and cancer treatments, is also contributing to market growth. Additionally, the increased demand for organ and tissue transplants is pushing the development of advanced cryopreservation systems that can maintain biological viability over extended periods, supporting the broader healthcare and biotechnology sectors.

Select Competitors (Total 36 Featured) -

• Antech Group Inc
• CellBios Healthcare and Lifesciences Pvt. Ltd.
• Charter Medical Ltd.
• Chemglass Life Sciences Inc.
• CryoLogic Pty. Ltd.
• Cryoport Systems, Inc.
• Custom BioGenic Systems
• Haimen United Laboratory Equipment Development Co., Ltd.
• Hamilton Company
• Linde Gas & Equipment Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.